On this page
Signal check
What changed—and what was not tested
The authors found inhibition with the intact heptapeptides and certain fragments, while other fragment lengths lacked the same effect. The assay does not establish analgesia, opioid interaction safety or a human treatment schedule.
[Semax and selank inhibit the enkephalin-degrading enzymes from human serum]]. (2001)
- Measured signal
- Enzyme inhibition by Semax, Selank and peptide fragments.
- Design
- In-vitro comparison of peptide effects on enkephalin-degrading enzymes.
- Population or preparation
- Human serum tested outside a treated patient.
- Reported change
- The authors found inhibition with the intact heptapeptides and certain fragments, while other fragment lengths lacked the same effect.
- Inference boundary
- The assay does not establish analgesia, opioid interaction safety or a human treatment schedule.
The experimental design
In-vitro comparison of peptide effects on enkephalin-degrading enzymes.
Who or what was studied
Human serum tested outside a treated patient.
The measurement
Enzyme inhibition by Semax, Selank and peptide fragments. For a separate account of aggregation responses to the modified peptides and parent compounds, read Semax-derived conjugates and platelets. For a separate account of changes in degradation after selected peptidase inhibitors, read Semax serum-enzyme research.
The reported finding
The authors found inhibition with the intact heptapeptides and certain fragments, while other fragment lengths lacked the same effect. Human material is not the same thing as a human administration study. Concentrations that inhibit an enzyme in a sample need not be reached at relevant sites after a particular product is used.
What the result cannot establish
The assay does not establish analgesia, opioid interaction safety or a human treatment schedule. Ask whether a mechanistic claim is supported by measured exposure and a relevant clinical outcome. Enzyme activity alone cannot establish what a person will feel or how medicines might interact. The consultation checklist can help you ask which part of this experimental result matches the preparation and goal under discussion.
A related comparison
Our membrane-binding and degradation guide also separates intact peptide from breakdown products. Fragment identity is an experimental variable, not an incidental abbreviation.
Evidence index
Original research and documented service details.